News

Blood Thinners

Federal Judge Orders Bristol-Myers Squibb and Sanofi To Pay $834 Million to Hawaii Over Plavix Label

Reuters | Equities.com |

Bristol-Myers Squibb Co and Sanofi SA were ordered by a U.S. judge on Monday to pay more than $834 million to the state of Hawaii for failing to properly warn non-white patients of health risks from its blood thinner Plavix.

The companies had failed to change the drug’s label to warn doctors and patients despite knowing some of the risks for more than a decade, U.S. District Judge Dean Ochiai in Honolulu wrote in the ruling.

Bristol-Myers and Sanofi, which produce Plavix in a partnership, said in a joint statement the decision was not supported by the overwhelming body of scientific evidence and vowed to appeal.


Mount Sinai Doctors Try Blood Thinners Amid Increasing Incidences of Clotting in COVID-19 Patients

Reuters | Equities.com |

As the novel coronavirus spread through New York City in late March, doctors at Mount Sinai Hospital noticed something strange happening to patients’ blood. Signs of blood thickening and clotting were being detected in different organs by doctors from different specialties. This would turn out to be one of the alarming ways the virus ravages the body, as doctors there and elsewhere were starting to realize. At Mount Sinai, nephrologists noticed kidne...


Sponsored Financial Content

Market Movers